Courtney has worked at UCSF as a senior project and program manager for 14 years, where she strategically develops, plans and implements precision medicine projects and programs. Courtney works closely with Keith Yamamoto to manage UCSF’s presence at the Precision Medicine World Conference, from strategic development, track and session planning, speaker preparation, logistics, communications and our physical presence. She has a background is biological sciences, neuroscience and pediatrics. Courtney is also a rare disease patient and advocate.
- Courtney McFall, UCSF
- Ben Rubin, UCSF
Patient-centric data – Real-World Evidence (RWE) and Real-World Data (RWD) - is becoming instrumental in the drug development process and for health care decisions in general. This data is not only informative for the process from discovery to new indications, clinical trial design, and drug development, it also can be of value to monitor post-marketing drug safety and for decision support in clinical practice. As the data becomes a decision driver, science companies and medical organizations are increasingly focused on leveraging RWD and RWE to not only better understand the patient populations using their drugs and the respective outcomes, but also to accelerate clinical decision support. This session will focus on the various aspects of integrating RWE and RWD to support drug development and clinical decision support.